HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Maxim Soloviev Selected Research
Maxim Soloviev Research Topics
Disease
4
Neoplasms (Cancer)
01/2022 - 01/2018
1
Lymphoma (Lymphomas)
01/2020
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2020
1
Hematologic Neoplasms (Hematological Malignancy)
01/2020
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2018
1
Pain (Aches)
01/2012
Drug/Important Bio-Agent (IBA)
1
Antibodies
IBA
01/2022
1
Ligands
IBA
01/2022
1
Programmed Cell Death 1 Receptor
IBA
01/2022
1
pemigatinib
IBA
01/2020
1
Cisplatin (Platino)
FDA Link
Generic
01/2020
1
parsaclisib
IBA
01/2020
1
Phosphatidylinositols (Phosphatidylinositol)
IBA
01/2020
1
Phosphotransferases (Kinase)
IBA
01/2020
1
Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)
IBA
01/2020
1
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
01/2018
1
Bendamustine Hydrochloride
FDA Link
01/2018
1
Carrageenan
IBA
01/2012
1
1- (7- (2- amino- 6- (4- methylpiperazin- 1- yl)pyrimidin- 4- yl)- 3,4- dihydroisoquinolin- 2(1H)- yl)- 2- cyclopentylethanone
IBA
01/2012
1
Histamine (Histamine Dihydrochloride)
FDA Link
01/2012
1
Formaldehyde (Formol)
FDA Link
01/2012
Therapy/Procedure
2
Therapeutics
01/2020 - 01/2018
1
Drug Tapering
01/2020